Safety and tolerability study of sotrovimab (VIR-7831) prophylaxis against COVID-19 infection in immunocompromised individuals with impaired SARS-CoV-2 humoral immunity.

Autor: Gonzalez-Bocco IH; Division of Infectious Disease, Dana-Farber Cancer Institute, Boston, MA, USA. Isabel_gonzalez-bocco@dfci.harvard.edu.; Division of Infectious Disease, Brigham and Women's Hospital, Boston, MA, USA. Isabel_gonzalez-bocco@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. Isabel_gonzalez-bocco@dfci.harvard.edu., Beluch K; Division of Infectious Disease, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Infectious Disease, Brigham and Women's Hospital, Boston, MA, USA., Cho A; Division of Infectious Disease, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Infectious Disease, Brigham and Women's Hospital, Boston, MA, USA., Lahoud C; Division of Infectious Disease, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Infectious Disease, Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Reyes FA; Division of Infectious Disease, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Infectious Disease, Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Moshovitis DG; Division of Infectious Disease, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Infectious Disease, Brigham and Women's Hospital, Boston, MA, USA., Unger-Mochrie GM; Division of Infectious Disease, Brigham and Women's Hospital, Boston, MA, USA., Wang W; Harvard Medical School, Boston, MA, USA.; Medicine Department, Brigham and Women's Hospital, Boston, MA, USA., Hammond SP; Division of Infectious Disease, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Division of Infectious Disease, Massachusetts General Hospital, Boston, MA, USA., Manne-Goehler J; Division of Infectious Disease, Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Division of Infectious Disease, Massachusetts General Hospital, Boston, MA, USA., Koo S; Division of Infectious Disease, Dana-Farber Cancer Institute, Boston, MA, USA. skoo@bwh.harvard.edu.; Division of Infectious Disease, Brigham and Women's Hospital, Boston, MA, USA. skoo@bwh.harvard.edu.; Harvard Medical School, Boston, MA, USA. skoo@bwh.harvard.edu.

Publikováno v: Pilot and feasibility studies [Pilot Feasibility Stud] 2023 Jun 16; Vol. 9 (1), pp. 100. Date of Electronic Publication: 2023 Jun 16.